Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,090 across all filing types
Latest filing 2017-09-25 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
信息披露管理制度（2017年9月）
Governance Information Classification · 95% confidence The document is titled "信息披露管理制度" which translates to "Information Disclosure Management System" for a company. It extensively discusses the principles, rules, and procedures for information disclosure, including legal and regulatory compliance, responsibilities of directors and management, types of reports (periodic and interim), disclosure of transactions, major events, and related filing requirements with regulatory bodies such as the Shenzhen Stock Exchange and China Securities Regulatory Commission. The content is a detailed governance and compliance manual for information disclosure rather than an actual financial report, earnings release, or announcement. It does not contain financial statements or results but rather the framework and rules for disclosures. This fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices related to disclosure and compliance.
2017-09-25 Chinese
重大投资和交易决策制度（2017年9月）
Governance Information Classification · 95% confidence The document is titled '重大投资和交易决策制度' which translates to 'Major Investment and Transaction Decision System' and outlines the company's internal policies and procedures for making decisions on significant investments and transactions. It references relevant laws and regulations, defines thresholds for transactions requiring board or shareholder approval, and details the decision-making authority within the company. There are no financial statements, audit results, or earnings data presented. The document is a governance-related internal policy document rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2017-09-25 Chinese
关联交易决策制度（2017年9月）
Governance Information Classification · 95% confidence The document is titled '关联交易决策制度' which translates to 'Related Party Transaction Decision System' and details the internal rules, procedures, and governance regarding related party transactions for the company. It includes definitions of related parties, approval processes, disclosure requirements, and board and shareholder meeting procedures related to these transactions. There is no indication that this is a financial report, audit, earnings release, or any other type of report. Instead, it is a governance document outlining internal policies and procedures. Therefore, the document fits best under the category of Governance Information (CGR). The document length (8036 characters) and content confirm it is a full policy document, not a brief announcement or regulatory filing.
2017-09-25 Chinese
对外担保管理制度（2017年9月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by 厦门艾德生物医药科技股份有限公司. It is a detailed internal policy document outlining the procedures, responsibilities, approval authorities, and disclosure requirements related to the company's external guarantees. The content includes governance rules, approval processes by the board and shareholders, risk management, contract signing, follow-up management, information disclosure, and accountability related to external guarantees. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. It is not a report publication announcement or a certification. The document is a governance and management policy document related to the company's internal control and risk management practices for external guarantees. Therefore, the most appropriate classification is Governance Information (CGR).
2017-09-25 Chinese
独立董事关于相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on several company matters, including the use of idle raised funds for cash management, use of idle own funds for cash management, and anticipated related party transactions for the year 2017. It references compliance with laws, company articles, and regulatory guidelines but does not contain financial statements or detailed financial data. The document is a formal opinion or statement related to governance and regulatory compliance rather than a full report or announcement of financial results. It is not an Annual Report, Interim Report, or Earnings Release. It is also not a report publication announcement or certification. The content aligns best with Board/Management Information (MANG) as it involves independent directors' opinions on company governance and operational matters.
2017-09-25 Chinese
累积投票制度实施细则（2017年9月）
Governance Information Classification · 100% confidence The document is titled as "累积投票制度实施细则" which translates to "Cumulative Voting System Implementation Rules" for the company. It details the procedures and rules for cumulative voting in the election of directors and supervisors, including voting rights, vote counting, and election procedures. It is a governance-related document focusing on the internal rules and procedures for board elections, referencing company bylaws and shareholder meeting rules. There is no financial data, no audit information, no earnings or capital updates, no legal proceedings, no voting results announcement, and no presentation or report publication. This document fits best under Governance Information (CGR) as it details the company's internal governance practices and board election procedures.
2017-09-25 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.